Suchergebnisse - "Anti-viral"

PubPharm (261)

1

Preliminary report on therapeutic potential of coal-derived carbon quantum dots against SARS-CoV-2 virus

enthalten in: Virology | 2024

von Saikia, B. | Roy, K. | Konwar, R.

2

Activation of protein kinase receptor (PKR) plays a pro-viral role in mammarenavirus-infected cells

enthalten in: Journal of virology | 2024

von Witwit, H. | Khafaji, R. | Salaniwal, A. | +7

UpdateOf: bioRxiv. 2023 Dec 06;:. - PMID 38106082

3

Novel therapeutic approaches for the management of hepatitis infections

enthalten in: Therapeutic delivery | 2024

von Damodaran, A. | Zachariah, S. | Nair, S.

4

Dual anti-viral treatment for persistent COVID-19 in immunocompromised hemato-oncological patients is associated with a favorable prognosis and minor side effects

enthalten in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy | 2024

von Meijer, S. | Halutz, O. | Adler, A. | +22

5

The role of ion dissolution in metal and metal oxide surface inactivation of SARS-CoV-2

enthalten in: Applied and environmental microbiology | 2024

von Hilton, J. | Nanao, Y. | Flokstra, M. | +6

6

Baicalin Protects Broilers against Avian Coronavirus Infection via Regulating Respiratory Tract Microbiota and Amino Acid Metabolism

enthalten in: International journal of molecular sciences | 2024

von Feng, H. | Zhang, J. | Wang, X. | +4

7

Antiviral Effects and Mechanisms of Green Tea Catechins on Influenza : A Perception on Combating Symptoms from COVID-19

enthalten in: Current topics in medicinal chemistry | 2024

von Man, G. | Zheng, X. | Hung, S. | +8

8

Evaluation of patients treated with direct-acting anti-viral therapy for chronic hepatitis C and their risk of hepatocellular carcinoma in Hong Kong

enthalten in: BMC gastroenterology | 2024

von Chow, V. | Cheung, W.

9

Drug repurposing of FDA-approved anti-viral drugs via computational screening against novel 6M03 SARS-COVID-19

enthalten in: Irish journal of medical science | 2024

von Waseem, W. | Zafar, R. | Jan, M. | +4

10

Olgotrelvir, a dual inhibitor of SARS-CoV-2 Mpro and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19

enthalten in: Med (New York, N.Y.) | 2024

von Mao, L. | Shaabani, N. | Zhang, X. | +38

ErratumIn: Med. 2024 Feb 9;5(2):169-171. - PMID 38340710

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[27]